[Study of the clinical and metabolic effects of a new anabolic drug in oral administration: methylitriendolone. 3. Secondary effects and conclusions].
D015068:17-Ketosteroids / Q000652:urine*; D045930:Anabolic Agents / Q000009:adverse effects*; D001663:Bilirubin / Q000097:blood*; D006801:Humans; D000637:Transaminases / Q000097:blood*
D015068:17-Ketosteroids; D045930:Anabolic Agents; D000637:Transaminases; D001663:Bilirubin
Studio sugli effetti clinici e metabolici di un nuovo anabolizzante per via orale: il metiltrienolone. 3. Effetti secondari e conclusinoi.